JOHNSON & JOHNSON (JNJ) vs STRYKER CORP (SYK)
Side-by-side comparison from SEC filings: latest annual financials, insider activity and institutional ownership.
| Metric | JNJ | SYK |
|---|---|---|
| Sector | Health Care | Health Care |
| Latest fiscal year | FY2025 | FY2025 |
| Revenue | $94.19B | $25.12B |
| Revenue growth (YoY) | ▲ 6.0% | ▲ 11.2% |
| Net income | $26.8B | $3.25B |
| Gross margin | 67.9% | 64.0% |
| Diluted EPS | $11.03 | $8.40 |
| Insider net (6 mo) | −40.8K sh • 7 sells • 0 buys | −666.1K sh • 8 sells • 0 buys |
| Institutional owners | 47 | 45 |
| Institutional value held | $294.77B | $58.13B |
| Next earnings (est.) | Around Jan 20, 2027 | Oct 29, 2026 |
Figures from each company's SEC filings (latest reported fiscal year; fiscal calendars may differ). Next-earnings dates are estimates from historical filing patterns.
About JOHNSON & JOHNSON (JNJ)
Johnson & Johnson, incorporated in New Jersey in 1887, is a global healthcare holding company with approximately 138,200 full-time-equivalent employees engaged in the research, development, manufacture, and sale of a broad range of healthcare products. Read more →
About STRYKER CORP (SYK)
Stryker Corporation is a global medical technology company, incorporated in Michigan in 1946 as successor to a business founded in 1941 by Dr. Homer H. Read more →
Source: SEC EDGAR.